Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Ari Raphael
29 tahun pengalaman
akreditasi :
Klinik telah bersertifikat :
| Israel | Turki | Austria | |
| Terapi sinar proton | dari $48,000 | dari $70,000 | dari $80,000 |
| Sistem Robotik Da Vinci | dari $22,500 | dari $9,500 | dari $22,000 |
| Operasi kanker paru-paru | dari $27,500 | dari $17,000 | dari $42,000 |
| Lobektomi | dari $23,171 | dari $7,300 | dari $30,000 |
| Kemoterapi untuk kanker paru-paru | dari $3,200 | dari $1,000 | dari $19,200 |
Profesor Ofer Merimsky mengkhususkan diri dalam kanker paru-paru dan telah mengembangkan protokol perawatan inovatif untuk penyakit stadium awal dan lanjut.
Dr. Ari Raphael memimpin uji klinis inovatif dalam kanker paru-paru di Sourasky Medical Center, yang berfokus pada profil genomik dan imunoterapi.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.